This is consistent with data on the control of the overactive glycolytic flux in cancer cells, where GAPDH was also identified as the rate-limiting step in the pathway and the level of Fru1,6bisP found to be predictive for the rate and control of glycolytic flux at GAPDH (17). The gene discussed is GAPDH; the disease is cancer.